Georgi Stavrakov

9PUBLICATIONS
9CO-AUTHORS
Biomolecular modelling and designMolecular targetsPredictive and prognostic markersBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Non-Classical Binding Mechanisms of Ferrocene-Modified Imatinib and Nilotinib Analogues in BCR-ABL1 Kinase Revealed by Computational Analysis.

|Feb 27, 2026
Rational Design, Synthesis, and Molecular Docking of Novel Terpene Analogues of Imatinib, and Their Inhibition on Downstream BCR-ABL Signaling.

Rositsa Mihaylova, Asine Dailova-Barzeva, Irena Philipova

|Aug 14, 2025
Design, Docking Analysis, and Structure-Activity Relationship of Ferrocene-Modified Tyrosine Kinase Inhibitors: Insights into BCR-ABL Interactions.

Irena Philipova, Mariyana Atanasova, Rositsa Mihaylova

|May 30, 2023
Ferrocene modified analogues of imatinib and nilotinib as potent anti-cancer agents.

Irena Philipova, Rositsa Mihaylova, Georgi Momekov

|Dec 11, 2022
Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine-Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice.

Rumyana Simeonova, Mariyana Atanasova, Georgi Stavrakov

|Jul 24, 2021
A Galantamine-Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells.

Kirilka Mladenova, Georgi Stavrakov, Irena Philipova

Pageof 2

Frequent Collaborators

7 joint publications

Mariyana Atanasova

5 joint publications

Irini Doytchinova

4 joint publications

Irena Philipova

3 joint publications

Rumyana Simeonova